Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rivaroxaban Estimation With Warfarin in Atrial Fibrillation Patients With Coronary Stent Implantation Study (REWRAPS)

NCT02024230 is registered in ClinicalTrials.gov with Fujita Health University as lead sponsor.

NCT NCT02024230
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02024230 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rivaroxaban Estimation With Warfarin in Atrial Fibrillation Patients With Coronary Stent Implantation Study (REWRAPS)
Lead sponsor
Fujita Health University
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2014
Completion date
December 31, 2022
Enrollment
500 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

all cause mortality, atrial fibrillation, coronary artery disease, fetal blood loss, major bleeding, stroke